Alerts will be sent to your verified email
Verify Email
SAROJA
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Saroja Pharma Industries India Limited specializes in trading and exporting Specialty Chemicals for pharmaceutical products. Dedicated to delivering cost-effective human and veterinary medicines with superior quality and service.
Saroja Pharma Ind major competitors are Parmax Pharma, Emmessar Biotech&Nut, iStreet Network, Link Pharma Chem, Chemo Pharma Labs, Desh Rakshak Aushdh, Venmax Drugs&Pharma.
Market Cap of Saroja Pharma Ind is ₹14 Crs.
While the median market cap of its peers are ₹17 Crs.
Saroja Pharma Ind seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | ||||||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
